Phase 3
April 21, 2022
APCER life sciences through its oncology expertise helped the pharma company manage its pharmacovigilance activites …
March 8, 2021
APCER helped a leading generics company to streamline its PV related processes within 30 days. …
March 8, 2021
We helped a large pharmaceutical company successfully transition its pharmacovigilance (PV) processes and helped establish …
March 8, 2021
APCER helped a global pharmaceutical company in establishing a collaborative global pharmacovigilance (PV) governance model; …
March 8, 2021
APCER Life Sciences supported a leading generic pharma company with managing the EU RMP requirements …
March 8, 2021
We helped a biopharma company to set up end-to-end Quality Management System (QMS) and successfully …
March 8, 2021
Our medical monitoring team with experience and expertise in early clinical development stages provided oversight …
March 8, 2021
APCER Life Sciences as a specialized PV partner helped the company to harmonize all its …
March 8, 2021
APCER Life Sciences supported an innovative pharma company in managing complex pharmacovigilance and regulatory requirements …